Marksans Pharma Limited

NSE MARKSANS.NS

Marksans Pharma Limited Debt to Equity Ratio for the year ending March 31, 2024: 0.12

Marksans Pharma Limited Debt to Equity Ratio is 0.12 for the year ending March 31, 2024, a 67.76% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.

Marksans Pharma Limited Debt to Equity Ratio for the year ending March 31, 2023 was 0.07, a -23.54% change year over year.
Marksans Pharma Limited Debt to Equity Ratio for the year ending March 31, 2022 was 0.09, a 139.52% change year over year.
Marksans Pharma Limited Debt to Equity Ratio for the year ending March 31, 2021 was 0.04, a -17.48% change year over year.
Marksans Pharma Limited Debt to Equity Ratio for the year ending March 31, 2020 was 0.05, a -74.77% change year over year.

Key data

Date	Debt to Equity Ratio	Debt to Income Ratio	Debt to Tangible Net Worth Ratio	Dividend Coverage Ratio

NSE: MARKSANS.NS

Marksans Pharma Limited

CEO	Mr. Mark B. Saldanha
IPO Date	July 19, 2002
Location	India
Headquarters	Grandeur
Employees	1,141
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Clinical Trials Drugstores & Retail Pharmacies

Description

Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antibiotic, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. It also provides contract research and manufacturing services. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.

Key trends

Past 5 years